IBDEI18U ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20796,1,3,0)
 ;;=3^Multi-System Degeneration of the Autonomic Nervous System
 ;;^UTILITY(U,$J,358.3,20796,1,4,0)
 ;;=4^G90.3
 ;;^UTILITY(U,$J,358.3,20796,2)
 ;;=^5004162
 ;;^UTILITY(U,$J,358.3,20797,0)
 ;;=G91.2^^99^985^26
 ;;^UTILITY(U,$J,358.3,20797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20797,1,3,0)
 ;;=3^NPH w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,20797,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,20797,2)
 ;;=^5004174^F02.81
 ;;^UTILITY(U,$J,358.3,20798,0)
 ;;=G91.2^^99^985^27
 ;;^UTILITY(U,$J,358.3,20798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20798,1,3,0)
 ;;=3^NPH w/ Dementia w/o Behavorial Disturbances
 ;;^UTILITY(U,$J,358.3,20798,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,20798,2)
 ;;=^5004174^F02.80
 ;;^UTILITY(U,$J,358.3,20799,0)
 ;;=G30.8^^99^985^2
 ;;^UTILITY(U,$J,358.3,20799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20799,1,3,0)
 ;;=3^Alzheimer's Disease NEC
 ;;^UTILITY(U,$J,358.3,20799,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,20799,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,20800,0)
 ;;=A81.89^^99^985^6
 ;;^UTILITY(U,$J,358.3,20800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20800,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,20800,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,20800,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,20801,0)
 ;;=F19.97^^99^985^35
 ;;^UTILITY(U,$J,358.3,20801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20801,1,3,0)
 ;;=3^Psychoactive Substance Use w/ Persisting Dementia NEC
 ;;^UTILITY(U,$J,358.3,20801,1,4,0)
 ;;=4^F19.97
 ;;^UTILITY(U,$J,358.3,20801,2)
 ;;=^5003465
 ;;^UTILITY(U,$J,358.3,20802,0)
 ;;=G20.^^99^985^28
 ;;^UTILITY(U,$J,358.3,20802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20802,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,20802,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,20802,2)
 ;;=^5003770^F02.81
 ;;^UTILITY(U,$J,358.3,20803,0)
 ;;=G20.^^99^985^29
 ;;^UTILITY(U,$J,358.3,20803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20803,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,20803,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,20803,2)
 ;;=^5003770^F02.80
 ;;^UTILITY(U,$J,358.3,20804,0)
 ;;=G23.1^^99^985^34
 ;;^UTILITY(U,$J,358.3,20804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20804,1,3,0)
 ;;=3^Progressive Supranuclear Palsy
 ;;^UTILITY(U,$J,358.3,20804,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,20804,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,20805,0)
 ;;=F03.91^^99^985^15
 ;;^UTILITY(U,$J,358.3,20805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20805,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,20805,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,20805,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,20806,0)
 ;;=F03.90^^99^985^17
 ;;^UTILITY(U,$J,358.3,20806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20806,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,20806,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,20806,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,20807,0)
 ;;=F06.30^^99^986^2
 ;;^UTILITY(U,$J,358.3,20807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20807,1,3,0)
 ;;=3^Depressive Disorder d/t Another Medical Condition,Unspec
 ;;^UTILITY(U,$J,358.3,20807,1,4,0)
 ;;=4^F06.30
 ;;^UTILITY(U,$J,358.3,20807,2)
 ;;=^5003056
 ;;^UTILITY(U,$J,358.3,20808,0)
 ;;=F06.31^^99^986^3
 ;;^UTILITY(U,$J,358.3,20808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20808,1,3,0)
 ;;=3^Depressive Disorder d/t Another Medical Condition w/ Depressive Features
